Option chain shows key data for Kyowa Kirin's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kyowa Kirin.

Kyowa Kirin (OTC:KYKOF) Stock, Option Chain

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Biotech

News

Penny Stocks

Previews

Small Cap

Trading Ideas

ABBV

ADMP

AGIO

ALKS

ALXN

APTO

AUTL

BGNE

BIIB

BLUE

CGEN

CHRS

CNST

CRIS

CRSP

CYAD

ELDN

FBIO

FMTX

GOSS

IMRA

IOVA

KDNY

KYKOF

LMNL

MBIO

MEIP

Morgan Stanley Capital Protected Notes for S&P 500 Index

NEXI

ONCT

PDSB

PGEN

PTGX

SCYX

VERA

VRTX

XFOR

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week, headlining the biotech news flow of the week.

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck

Health Care

Contracts

General

CERC

Cerecor Inc&#39;s (NASDAQ: CERC) wholly-owned subsidiary, Aevi Genomic Medicine LLC, has 

Comments

Kyowa Kirin

Kyowa Kirin (KYKOF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga